glp-1 agonists drug class for Weight Loss: Safe or Risky? America's Poison Centers - GLP-1
Description
GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients with Type 2 Diabetes
doi: 10.1007/s00125-006-0510-2
The concept of the circadian rhythmicity in the human secretion of renin and aldosterone, under the influence of posture, sodium intake and age, is well known from decades (26)
GI side effects are uniformly higher with retatrutide, reflecting the additional receptor stimulation
Role of renal sympathetic nerves in GLP-1 (glucagon-like peptide-1) receptor agonist exendin-4-mediated diuresis and natriuresis in diet-induced obese rats
